Neuron23
neuron23.comFair
1
Fair
1
40
40
Mar 4, 2026
Neuron23 is a biotechnology company focused on developing precision medicines for neurological and immunological disorders, with a particular emphasis on genetically defined targets. The brand has moderate AI visibility primarily in specialized healthcare and biotech contexts, but lacks broader mainstream recognition. My training data contains some coverage of its scientific focus and funding activities, though detailed information about specific drug candidates or clinical progress appears limited. Within its target market of biotech investors and healthcare professionals, AI systems can provide basic identification but may struggle with comprehensive, up-to-date information.
How well AI models identify your brand
How accurately AI describes your business
How thoroughly AI covers your offerings
How positively AI portrays your brand
| Date | Score | Rating | View |
|---|---|---|---|
Mar 4, 2026 | 40 | Fair | View Details |
Book an AI Search Audit to understand which AI search gaps need to be fixed first.